Literature DB >> 14991532

Occludin expression decreases with the progression of human endometrial carcinoma.

Hirotoshi Tobioka1, Hiroshi Isomura, Yasuo Kokai, Yuichi Tokunaga, Jun Yamaguchi, Norimasa Sawada.   

Abstract

The tight junctions of the glandular epithelium are crucial for the maintenance of cell polarity, separating the plasma membrane into apical and basolateral domains. Thus abnormalities of the tight junctions may result in the structural disturbances of glandular epithelial neoplasia. In this study we introduced an anti-occludin monoclonal antibody for semiquantitative assay of the occludin expression in tissue sections of human normal and neoplastic endometrial epithelia using the Adobe Photoshop and NIH Image programs. Normal endometrial glands and samples of endometrial hyperplasia and endometrioid carcinoma grade 1 fully expressed occludin at the apical cell border. In endometrioid carcinomas grades 2 and 3, however, occludin disappeared in solid areas of the carcinomatous tissues. Occludin was also found at the apical borders of the cancer cells that formed glandular structures. Occludin expression decreased progressively in parallel with the increase in carcinoma grade, and the decreased occludin expression correlated with myometrial invasion and lymph node metastasis. These results suggest that the loss of tight junctions has a close relationship with structural atypia in the progression of human endometrial carcinomas and their malignant potential.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14991532     DOI: 10.1016/j.humpath.2003.09.013

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  39 in total

Review 1.  Tight junctions in lung cancer and lung metastasis: a review.

Authors:  Ylermi Soini
Journal:  Int J Clin Exp Pathol       Date:  2012-02-12

2.  Glycogen Synthase Kinase 3 (GSK-3) influences epithelial barrier function by regulating occludin, claudin-1 and E-cadherin expression.

Authors:  Eric A Severson; Mike Kwon; Roland S Hilgarth; Charles A Parkos; Asma Nusrat
Journal:  Biochem Biophys Res Commun       Date:  2010-07-02       Impact factor: 3.575

3.  Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer.

Authors:  Punita Dhawan; Amar B Singh; Natasha G Deane; Yiran No; Sheng-Ru Shiou; Carl Schmidt; John Neff; M Kay Washington; R Daniel Beauchamp
Journal:  J Clin Invest       Date:  2005-06-16       Impact factor: 14.808

Review 4.  Epithelial cell polarity and tumorigenesis: new perspectives for cancer detection and treatment.

Authors:  Danila Coradini; Claudia Casarsa; Saro Oriana
Journal:  Acta Pharmacol Sin       Date:  2011-04-18       Impact factor: 6.150

5.  Occludin localizes to centrosomes and modifies mitotic entry.

Authors:  E Aaron Runkle; Jeffrey M Sundstrom; Kristin B Runkle; Xuwen Liu; David A Antonetti
Journal:  J Biol Chem       Date:  2011-07-12       Impact factor: 5.157

6.  The expression patterns of tight junction protein claudin-1, -3, and -4 in human gastric neoplasms and adjacent non-neoplastic tissues.

Authors:  Haiming Wang; Xingwang Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

Review 7.  Polarity proteins as regulators of cell junction complexes: implications for breast cancer.

Authors:  Dana Bazzoun; Sophie Lelièvre; Rabih Talhouk
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

8.  Holding Tight: Cell Junctions and Cancer Spread.

Authors:  Alexander J Knights; Alister P W Funnell; Merlin Crossley; Richard C M Pearson
Journal:  Trends Cancer Res       Date:  2012

9.  Claudin 1 in breast tumorigenesis: revelation of a possible novel "claudin high" subset of breast cancers.

Authors:  Yvonne Myal; Etienne Leygue; Anne A Blanchard
Journal:  J Biomed Biotechnol       Date:  2010-05-13

10.  Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype.

Authors:  Anne A Blanchard; George P Skliris; Peter H Watson; Leigh C Murphy; Carla Penner; Ladislav Tomes; Tamara L Young; Etienne Leygue; Yvonne Myal
Journal:  Virchows Arch       Date:  2009-04-23       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.